State Street Corp Calyxt, Inc. Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.02 - $2.46 $2,264 - $5,461	-2,220 Reduced 5.5%	38,112 $40,000
Q3 2021 Nov 15, 2021	SELL	$3.18 - $5.08 $2,544 - $4,064	-800 Reduced 1.94%	40,332 $136,000
Q2 2021 Aug 16, 2021	SELL	$3.83 - $6.31 $553,645 - $912,142	-144,555 Reduced 77.85%	41,132 $165,000
Q1 2021 May 17, 2021	BUY	$4.25 - $12.01 $46,486 - $131,365	10,938 Added 6.26%	185,687 $1.12 Million
Q4 2020 Feb 16, 2021	BUY	$3.21 - $5.68 $9,690 - $17,147	3,019 Added 1.76%	174,749 $737,000
Q3 2020 Nov 10, 2020	BUY	$4.37 - $7.66 $3,421 - $5,997	783 Added 0.46%	171,730 $943,000
Q2 2020 Aug 14, 2020	BUY	$2.9 - $6.36 $26,555 - $58,238	9,157 Added 5.66%	170,947 $843,000
Q1 2020 May 11, 2020	BUY	$2.48 - $7.85 $401,239 - $1.27 Million	161,790 New	161,790 $539,000

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.